Induction of New Autoimmune Diseases After Alemtuzumab Therapy for Multiple Sclerosis: Learning From Adversity
JAMA Neurol
.
2017 Aug 1;74(8):907-908.
doi: 10.1001/jamaneurol.2017.0325.
Author
Lawrence Steinman
1
Affiliation
1
Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.
PMID:
28604941
DOI:
10.1001/jamaneurol.2017.0325
No abstract available
Publication types
Comment
MeSH terms
Alemtuzumab*
Autoimmune Diseases
Humans
Lymphocytes
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting
Substances
Alemtuzumab